BioWorld

Nov. 5, 1992

View Archived Issues

HUMANIZED VERSION OF MURINE ANTIBODY

Read More

Exogene Contract with SmithKline Extended

Read More

LILLY PAYMENT TO ORGANOGENESIS DELAYED

Read More

SYSTEMIC APPLICATIONS FOR LIDAKOL

Read More

CELLCOR'S SCIENTIFIC FOUNDER RESIGNS

Read More

GREENWICH BEGINS PHASE II TRIALS

Read More

CD44 PINPOINTS MALIGNANT CELLS

Read More

APPLIED DNA SYSTEMS FOR SALE

Read More

CYTEL'S MAB BLOCKS INFLAMMATION

Read More